Related Experiment Videos
Modified varicella-like syndrome
1Division of General Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
Infectious Disease Clinics of North America
|September 1, 1996
Summary
Vaccinees can experience mild breakthrough infections, known as modified varicella-like syndrome (MVLS), after natural varicella exposure. This syndrome is less severe and infrequently transmitted compared to natural chickenpox.
Area of Science:
- Infectious Diseases
- Vaccinology
- Pediatrics
Background:
- Varicella (chickenpox) is a common childhood illness.
- Vaccination aims to prevent or reduce the severity of varicella infections.
- Breakthrough infections can occur in vaccinated individuals.
Purpose of the Study:
- To characterize modified varicella-like syndrome (MVLS) in varicella vaccine recipients.
- To compare the incidence and severity of MVLS to natural varicella.
- To assess the transmission potential of MVLS.
Main Methods:
- Post-vaccination follow-up of varicella vaccine recipients.
- Comparison of MVLS cases with natural varicella in unvaccinated children.
- Analysis of secondary transmission events.
Main Results:
- Up to 18% of vaccinees experienced MVLS after natural varicella exposure over 10 years.
- MVLS cases were generally asymptomatic or mild, with fewer lesions, less fever, and shorter duration than natural varicella.
- MVLS demonstrated infrequent secondary transmission.
Conclusions:
- Modified varicella-like syndrome is a mild, infrequently transmitted condition in varicella vaccinees.
- MVLS represents a less severe outcome compared to natural varicella.
- The study highlights the effectiveness of the varicella vaccine in mitigating disease severity.